Phoenix, AZ – BlueStone portfolio company, GT Medical Technologies, Inc. received the Innovator of the Year Award in the Small Company category (companies with less than $50M in revenue) at the Governor’s Celebration of Innovation, an awards ceremony put on by the Arizona Technology Council and the Arizona Commerce Authority. READ MORE

Tempe, AZ – GT Medical Technologies, Inc. today announced it is presenting clinical data in two oral presentations on the company’s breakthrough GammaTile® Therapy for patients with brain tumors at the 2021 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting. The presenting authors, Dr. David Brachman, co-founder and CTO at GT Medical Technologies and Dr. Mehee Choi, director…

Tucson, AZ – Pyx Health, a tech-enabled services company providing health plans and their members an innovative, scalable solution that effectively addresses the nation’s critical loneliness epidemic, announced today that it has received a strategic investment from Rallyday Partners, a Denver-based private equity investment firm. The funding will enable Pyx Health to enhance and scale its service…

Tucson, AZ – Pyx Health, a tech-enabled services company providing health plans and their members an innovative, scalable solution that effectively addresses A white paper reveals that Banner University Health Plans’ use of a novel interactive platform-plus-support center with members after discharge from emergency room or inpatient care resulted in a substantial reduction in subsequent inpatient costs…

Tempe, AZ – GT Medical Technologies Inc. had a very productive year in 2020 when it came to publishing about key aspects of GammaTile® Therapy. This included 4 publications in peer-reviewed journals, 9 abstracts presented at a variety of industry conferences,  and 1 white paper detailing access to care for radiation therapy in the US.  READ MORE

GT Medical Technologies Inc. has raised $16 million to expand its commercialization of a targeted radiation therapy for patients with brain tumors. Led by London-based private equity firm MVM Partners LLP, this latest round follows a $10 million raise in early 2019, bringing its total raise to $29 million. Existing investors San Francisco-based MedTech Venture…

Tempe, Arizona – BlueStone portfolio company, GT Medical Technologies, today announced new data from a clinical study of the company’s GammaTile® Therapy in patients with large brain metastases, or tumors that spread to the brain from cancer in another part of the body. Approximately 150,000 – 200,000 people are diagnosed with brain metastases each year in the…

Tempe, Arizona – BlueStone portfolio company, GT Medical Technologies, was named to Medical Design & Outsourcing  20 Medical Device Startups You Need to Know List. READ MORE

Tempe, Arizona –The MedTech world is about more than just building better medical devices. It’s also about technologies that, when applied with ingenuity, can help accelerate the entire biopharma enterprise. This means leveraging CRISPR-based gene-editing techniques to make it cheaper and easier to translate ideas into therapies, or to build more-sensitive and shelf-stable diagnostic tests—or even to make…

Tucson, Arizona –BlueStone Venture Partners announces the acquisition of one of its portfolio companies, Paradigm Diagnostics, Inc (“Paradigm”) by Exact Sciences Corporation (“Exact Sciences”). On March 3, Exact Sciences of Madison, Wisconsin, announced the completion of its acquisition of Paradigm and Viomics, cancer diagnostics companies based in Phoenix, Arizona.  Paradigm enables Exact Sciences to expand its…

Tempe, Arizona –GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for GammaTile® Therapy. Patients with newly diagnosed malignant brain tumors are now eligible to receive the FDA-cleared surgically targeted radiation therapy (STaRT) ​We are…

Chandler, Arizona –The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards. Approximately 400,000 Americans are newly diagnosed with some type of brain tumor each year. For decades, clinicians have sought better treatments for these…

Scottsdale, Arizona & Tempe, Arizona – HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with all types of recurrent brain tumors.…

Tempe, Arizona – GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced the presentation of clinical data from a prospective study of GammaTile® Therapy in patients with previously irradiated intracranial neoplasms (brain tumors) at the American Brachytherapy Society (ABS) 2019 Annual Meeting in Miami. These data reinforce the…

Tempe, Arizona – GT Medical Technologies has created a new way to target brain tumors like the type that took the late Senator John McCain’s life. GammaTile technology, invented and developed in Arizona, consists of four tiles implanted in a patient. These tiles contain dosages of radiation that targets glioblastomas. We’ll get more from Dr. David…

Tempe, Arizona –Listen to The Health Technology podcast from UCSF Rosenman Institute to hear GT Medical Technologies, Inc. CEO Matt Likens share how GammaTile Therapy challenges the current standard of care for patients with recurrent brain tumors by improving quality of life and delaying time to recurrence for all tumor pathologies (gliomas, meningiomas, metastases, etc.). LISTEN HERE

Tempe, Arizona & San Diego, California – BlueStone portfolio company GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that Peter Nakaji, M.D., GT MedTech’s co-founder and director of the Neurosurgery Residency Program at Barrow Neurological Institute in Phoenix, has been selected by the American Association of Neurological…

Tempe, Arizona & Minneapolis, Minnesota –  University of Minnesota Health (M Health) is the first health system in the United States to begin offering GammaTile Therapy™, a new approach to treating recurrent brain tumors. GammaTile Therapy is an FDA-cleared, surgically targeted radiation therapy (STaRT™) that is designed to delay tumor regrowth for patients with brain tumors.…

Minneapolis, Minnesota –  It sounds like science fiction, but doctors at University of Minnesota Health are the first in the country to offer an implantable form of radiation to target brain cancer. The implant is called GammaTile Therapy and Linda Tinega was the first patient in Minnesota to receive it.  “Each tile, has four, radioactive seeds on…